DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2024.Second Quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Guidance Stock Buybacks

DexCom (DXCM) PT Lowered to $145 at RBC CapitalJuly 26, 2024 6:34 AM Baird Downgrades DexCom (DXCM) to NeutralJuly 26, 2024 6:18 AM DexCom (DXCM) PT Lowered to $95 at UBSJuly 26, 2024 5:57 AM DexCom (DXCM) PT Lowered to $89 at Canaccord GenuityJuly 26, 2024 5:40 AM Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase ProgramJuly 25, 2024 4:03 PM